Altimmune (ALT) FCF Margin (QoQ) (2010 - 2025)
Powered by 
Analysis
Altimmune (ALT) FCF Margin (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Altimmune | 636.07 Mn | 636.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 16.31 Mn |
| Sep 30, 2025 | 14.91 Mn |
| Jun 30, 2025 | -5.02 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | 17.71 Mn |
| Sep 30, 2024 | -18.02 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Mar 31, 2024 | -28.25 Mn |
| Dec 31, 2023 | -3.90 Mn |
| Sep 30, 2023 | 31.73 Mn |
| Jun 30, 2023 | -23.03 Mn |
| Mar 31, 2023 | -2.59 Mn |
| Dec 31, 2022 | 68.88 Mn |
| Sep 30, 2022 | -54.65 Mn |
| Jun 30, 2022 | -16.67 Mn |
| Mar 31, 2022 | -4.16 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 813,489.00 |
| Jun 30, 2021 | -1.66 Mn |
| Mar 31, 2021 | -225,866.00 |